Literature DB >> 15249353

Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial.

Olga Vaccaro1, Lynn E Eberly, James D Neaton, Lingfeng Yang, Gabriele Riccardi, Jeremiah Stamler.   

Abstract

BACKGROUND: The magnitude of coronary mortality risk associated with diabetes or prior myocardial infarction (MI) is debatable. Modulating effects of age, risk factors, and duration of follow-up may explain discrepancies in previous research. Associations with noncardiovascular mortality are little explored.
OBJECTIVES: To compare mortality patterns in men with a history of diabetes or MI and to assess modulating effects on mortality of age, cardiovascular risk factors, and follow-up duration.
METHODS: We compared the 25-year mortality of 4809 men with diabetes only and 4625 men with MI only (all men aged 35-57 years).
RESULTS: The adjusted hazard ratio (HR) for all-cause mortality for those with MI only vs those with diabetes only was 0.97 (95% confidence interval, 0.92-1.03; P =.32). The pattern of deaths was different: higher coronary mortality (HR = 1.37; P<.001) and lower mortality from noncardiovascular causes (HR = 0.66; P<.001) in those with MI only compared with those with diabetes only. This finding prevailed across all ages and levels of cardiovascular risk factors. Hazard ratios for coronary mortality significantly declined over follow-up (2.7, 1.7, 1.2, 1.1, and 1.0 for < or =5, 6-10, 11-15, 16-20, and >20 years of follow-up, respectively), whereas HRs for noncardiovascular mortality remained relatively constant.
CONCLUSIONS: Overall, diabetes and MI were similarly strong predictors of total mortality. Higher mortality from noncardiovascular causes was observed in those with diabetes only, whereas prior MI was more strongly predictive of coronary mortality than diabetes at any age and level of cardiovascular risk factors. The difference in coronary mortality between the 2 groups was most evident in the first 10 years of follow-up.

Entities:  

Mesh:

Year:  2004        PMID: 15249353     DOI: 10.1001/archinte.164.13.1438

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  39 in total

Review 1.  Insulin resistance and atherosclerosis.

Authors:  Babak Razani; Manu V Chakravarthy; Clay F Semenkovich
Journal:  Endocrinol Metab Clin North Am       Date:  2008-09       Impact factor: 4.741

2.  Effects of antihypertensive treatments on incidence of diabetes: a case-control study.

Authors:  M Monami; A Ungar; C Lamanna; G Bardini; L Pala; I Dicembrini; C Marchi; M Vivarelli; S Zannoni; N Bartoli; N Marchionni; C M Rotella; E Mannucci
Journal:  J Endocrinol Invest       Date:  2011-05-24       Impact factor: 4.256

3.  Variation of serum monocyte chemoattractant protein-1 in patients with diabetes and metabolic syndrome.

Authors:  Huiqing Li; Xiuling Deng; Zhenqiong Li; Changqing Luo; Jianshe Liu; Yumei Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-06-14

4.  The effect of diabetes and stroke at baseline and during follow-up on stroke mortality.

Authors:  G Hu; P Jousilahti; C Sarti; R Antikainen; J Tuomilehto
Journal:  Diabetologia       Date:  2006-08-01       Impact factor: 10.122

5.  ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: diagnostic-therapeutic pathway in Italy.

Authors:  Michele Massimo Gulizia; Furio Colivicchi; Gualtiero Ricciardi; Simona Giampaoli; Aldo Pietro Maggioni; Maurizio Averna; Maria Stella Graziani; Ferruccio Ceriotti; Alessandro Mugelli; Francesco Rossi; Gerardo Medea; Damiano Parretti; Maurizio Giuseppe Abrignani; Marcello Arca; Pasquale Perrone Filardi; Francesco Perticone; Alberico Catapano; Raffaele Griffo; Federico Nardi; Carmine Riccio; Andrea Di Lenarda; Marino Scherillo; Nicoletta Musacchio; Antonio Vittorio Panno; Giovanni Battista Zito; Mauro Campanini; Leonardo Bolognese; Pompilio Massimo Faggiano; Giuseppe Musumeci; Enrico Pusineri; Marcello Ciaccio; Enzo Bonora; Giorgio Cantelli Forti; Maria Pia Ruggieri; Claudio Cricelli; Francesco Romeo; Roberto Ferrari; Attilio Maseri
Journal:  Eur Heart J Suppl       Date:  2017-05-02       Impact factor: 1.803

6.  Coronary risk equivalence of diabetes assessed by SPECT-MPI.

Authors:  Donna Chelle V Morales; Sanjeev P Bhavnani; Alan W Ahlberg; Raja C Pullatt; Deborah M Katten; Donna M Polk; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2017-12-06       Impact factor: 5.952

7.  Trends of hospitalizations, fatality rate and costs for acute myocardial infarction among Spanish diabetic adults, 2001-2006.

Authors:  Ana Lopez-de-Andres; Valentín Hernández-Barrera; Pilar Carrasco-Garrido; Jesús Esteban-Hernandez; Angel Gil-de-Miguel; Rodrigo Jiménez-García
Journal:  BMC Health Serv Res       Date:  2010-03-08       Impact factor: 2.655

8.  Long-term cardiovascular risk in type 2 diabetic compared with nondiabetic first acute myocardial infarction patients: a population-based cohort study in southern Europe.

Authors:  J Francisco Cano; Jose M Baena-Diez; Josep Franch; Joan Vila; Susana Tello; Joan Sala; Roberto Elosua; Jaume Marrugat
Journal:  Diabetes Care       Date:  2010-06-08       Impact factor: 19.112

9.  New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a Middle East population.

Authors:  Farzad Hadaegh; Nooshin Fahimfar; Davood Khalili; Farhad Sheikholeslami; Fereidoun Azizi
Journal:  Cardiovasc Diabetol       Date:  2010-12-04       Impact factor: 9.951

10.  Glucose intolerance and risk of cardiovascular disease in Iranian men and women: results of the 7.6-year follow-up of the Tehran Lipid and Glucose Study (TLGS).

Authors:  F Hadaegh; D Khalili; N Fahimfar; M Tohidi; F Eskandari; F Azizi
Journal:  J Endocrinol Invest       Date:  2009-10       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.